BAX — Bearish (ASignal Rank 4/4)
ASignal's 10+ AI agent pipeline rates BAX as Bearish with 79% confidence in the Healthcare sector.
AI Analysis Summary
BAX presents significant financial and operational risks with a bearish outlook, warranting avoidance due to extreme leverage, negative profitability, and a 36% projected price decline.
Investment Framework Assessment
Evaluated through three legendary investor frameworks:
- Warren Buffett (Value Investing): Grade D — 25/100
- Bill Ackman (Activist Investing): Grade B — 57/100
- Ray Dalio (Macro/Risk Parity): Grade D — 40/100
Consensus: Bearish
Price Intelligence
- Current price: $18.04
- Price target: $17.36 (-3.8%)
- Risk level: high
- Horizon: medium term
Quality Assessment
- Balance sheet: concerning
- Cash flow: fair
- Competitive moat: none
Peer Group Analysis
BAX is in the “Strong Cash Flow” cluster alongside WSM, WY, WTW, WMT, WELL (127 stocks total). 2 of 127 peers are currently bullish.